Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $307.00 million. The enterprise value is $17.00 million.

Market Cap	307.00M
Enterprise Value	17.00M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ATXS has 56.43 million shares outstanding. The number of shares has increased by 59.04% in one year.

Current Share Class	56.43M
Shares Outstanding	56.43M
Shares Change (YoY)	+59.04%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	59.59%
Float	30.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.58
P/TBV Ratio	1.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.39, with a Debt / Equity ratio of 0.02.

Current Ratio	17.39
Quick Ratio	16.93
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.89% and return on invested capital (ROIC) is -23.48%.

Return on Equity (ROE)	-32.89%
Return on Assets (ROA)	-22.56%
Return on Invested Capital (ROIC)	-23.48%
Return on Capital Employed (ROCE)	-42.46%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.69% in the last 52 weeks. The beta is 0.38, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-39.69%
50-Day Moving Average	4.89
200-Day Moving Average	7.86
Relative Strength Index (RSI)	52.05
Average Volume (20 Days)	385,541

Short Selling Information

The latest short interest is 3.14 million, so 5.57% of the outstanding shares have been sold short.

Short Interest	3.14M
Short Previous Month	3.02M
Short % of Shares Out	5.57%
Short % of Float	10.45%
Short Ratio (days to cover)	5.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-124.40M
Pretax Income	-81.63M
Net Income	-108.04M
EBITDA	n/a
EBIT	-124.40M
Earnings Per Share (EPS)	-$1.88

Balance Sheet

The company has $295.06 million in cash and $5.06 million in debt, giving a net cash position of $290.00 million or $5.14 per share.

Cash & Cash Equivalents	295.06M
Total Debt	5.06M
Net Cash	290.00M
Net Cash Per Share	$5.14
Equity (Book Value)	289.29M
Book Value Per Share	3.44
Working Capital	285.54M

Cash Flow

In the last 12 months, operating cash flow was -$96.14 million and capital expenditures -$325,000, giving a free cash flow of -$96.46 million.

Operating Cash Flow	-96.14M
Capital Expenditures	-325,000
Free Cash Flow	-96.46M
FCF Per Share	-$1.71

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.04%
Shareholder Yield	-59.04%
Earnings Yield	-35.19%
FCF Yield	-31.42%

Analyst Forecast

The average price target for ATXS is $32.43, which is 496.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.43
Price Target Difference	496.14%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-20.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1